These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3977518)

  • 1. Hereditary warfarin resistance. Investigation of a rare phenomenon.
    Alving BM; Strickler MP; Knight RD; Barr CF; Berenberg JL; Peck CC
    Arch Intern Med; 1985 Mar; 145(3):499-501. PubMed ID: 3977518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting warfarin maintenance dosage based on initial response.
    Miller DR; Brown MA
    Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary warfarin resistance].
    Lappegård KT
    Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3257-8. PubMed ID: 11187165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired warfarin resistance and weight-reducing diet.
    Qureshi GD; Reinders TP; Swint JJ; Slate MB
    Arch Intern Med; 1981 Mar; 141(4):507-9. PubMed ID: 7212893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the dose of warfarin for therapeutic anticoagulation.
    Sharma NK; Routledge PA; Rawlins MD; Davies DM
    Thromb Haemost; 1982 Jun; 47(3):230-1. PubMed ID: 7112495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin-induced skin necrosis: report of four cases.
    Horn JR; Danziger LH; Davis RJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1763-8. PubMed ID: 7030072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma warfarin levels and variations in steady-state prothrombin times.
    White RH; Zhou H; Romano P; Mungall D
    Clin Pharmacol Ther; 1995 Nov; 58(5):588-93. PubMed ID: 7586953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.
    O'Reilly RA
    Arch Intern Med; 1984 May; 144(5):989-91. PubMed ID: 6324710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of fortified wine ingested during fasting and anticoagulant therapy.
    O'Reilly RA
    Arch Intern Med; 1981 Mar; 141(4):458-9. PubMed ID: 7212888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of plasma prothrombin level by Ca2+-dependent prothrombin activator (CA-1) during warfarin anticoagulation.
    Iwahashi H; Kimura M; Nakajima K; Yamada D; Morita T
    J Heart Valve Dis; 2001 May; 10(3):388-92. PubMed ID: 11380105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of plasma (R)- & (S)-warfarin and vitamin K concentrations to intra-individual variability in anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Feb; 83(2):349-50. PubMed ID: 10739399
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium.
    Crussell-Porter LL; Rindone JP; Ford MA; Jaskar DW
    Arch Intern Med; 1993 Jan; 153(1):102-4. PubMed ID: 8422191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance to antivitamins K].
    Sánchez Villegas JM; Piqueras J; Nicolau I; Picó M; Soler JA; Monasterio J
    Sangre (Barc); 1992 Aug; 37(4):297-8. PubMed ID: 1514145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin resistance: diagnosis and therapeutic alternatives.
    Hulse ML
    Pharmacotherapy; 1996; 16(6):1009-17. PubMed ID: 8947972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary warfarin resistance.
    Diab F; Feffer S
    South Med J; 1994 Mar; 87(3):407-9. PubMed ID: 8134868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary related plasma vitamin C concentration has no effect on anticoagulation response to warfarin.
    Wynne H; Khan T; Avery P; Wood P; Ward A; Kamali F
    Thromb Res; 2006; 118(4):501-4. PubMed ID: 16139332
    [No Abstract]   [Full Text] [Related]  

  • 18. Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy.
    Sobieraj DM; Wang F; Kirton OC
    Pharmacotherapy; 2008 Dec; 28(12):1537-41. PubMed ID: 19025435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.
    O'Reilly RA; Trager WF; Motley CH; Howald W
    J Clin Invest; 1980 Mar; 65(3):746-53. PubMed ID: 7354137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential interaction between pomegranate juice and warfarin.
    Komperda KE
    Pharmacotherapy; 2009 Aug; 29(8):1002-6. PubMed ID: 19637955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.